Posted inBiotechnology
FDA gene therapy regulator Vijay Kumar steps down from leadership role
Vijay Kumar, the acting head of the FDA office that oversees new gene therapies, is stepping down from his role…
Posted inBiotechnology
Abivax rebounds from stock drop with safety data for much-hyped colitis prospect
Abivax has recovered from a dent in its share price after unveiling fresh safety data that appeared to ease investors’…
Posted inBiotechnology
Biotechs ‘in better position to avoid workforce reductions’ as layoffs continue to ease in Q2’26
A sharp reduction in layoffs continued in the second quarter, extending a trend that started last fall.
Posted inBiotechnology
Vistagen fails another phase 3 social anxiety trial but spies path to market
Vistagen’s social anxiety disorder drug candidate has flunked another phase 3 trial. But, with a post hoc subpopulation analysis linking…
Posted inBiotechnology
Deerfield’s Boulevard Bio pens $1.6B deal for trispecific TCE from China’s Metis TechBio
U.S.-based Boulevard Bio is paying $20 million upfront to China’s Metis TechBio for the global rights to a trispecific T-cell…
Posted inBiotechnology
Praxis faces FDA decision delay as analysts point finger at agency layoffs
The FDA has delayed a decision on the approval of Praxis Precision Medicine’s rare epilepsy prospect by three months. TD…
Posted inGenetics
Two Proteins with Opposing Functions Found to Support Healthy Skin Maintenance
Research headed by a team at Stanford Medicine has identified two proteins with opposing functions that are involved in orchestrating…
Posted inGenetics
Schistosomiasis Vaccine Shows Strong Immune Memory in Early Clinical Trials
Illustration of a schistosoma [SCIEPRO / Science Photo Library / Getty images] Helminth parasites of the Schistosoma genus cause roughly…
Posted inGenetics
Iron Accumulation Drives Neurodegeneration via Chronic Stress Pathway
Credit: koto_feja / E+/ Getty Images Neurodegenerative diseases affect tens of millions of people worldwide. A new study published in…
Posted inGenetics
Shilpa Commissions Integrated ADC Drug Substance GMP Manufacturing Facility
Credit: Shilpa Biologicals India-based Shilpa Biologicals commissioned an antibody–drug conjugate (ADC) GMP manufacturing facility, purpose-built and designed to meet global…